Treosulfan-based Conditioning for Transplantation in AML/MDS
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE4
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML
- Status
- COMPLETED
- Phase
- PHASE3
NOPHO-AML 2004 Study for Children With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
IV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE3
Busulfan, Fludarabine, Clofarabine With Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Intermittent Liposomal Amphotericin B Primary Prophylaxis
- Status
- UNKNOWN
- Phase
- PHASE2
Timed-Sequential Induction in CBF-AML
- Status
- COMPLETED
- Phase
- PHASE3
Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML)
- Status
- COMPLETED
- Phase
- PHASE2
Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary Aspergillosis
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Clofarabine for Older Patients With Newly Diagnosed Acute Myelogenous Leukemia (AML) (CLASSIC II)
- Status
- COMPLETED
- Phase
- PHASE2